Quality of life of prostate cancer (PCa) patients with testosterone deficiency symptoms (TDS) before initiation of gonadotropin-releasing hormone (GnRH) agonist therapy: Subgroup analysis of EQUINOXE study.

Stéphane Droupy,Marie-Hélène Colson,Nathalie Pello Leprince Ringuet,Valérie Perrot,Aurélien Descazeaud

Quality of life of prostate cancer (PCa) patients with testosterone deficiency symptoms (TDS) before initiation of gonadotropin-releasing hormone (GnRH) agonist therapy: Subgroup analysis of EQUINOXE study.

2020

Stéphane Droupy
Marie-Hélène Colson
Nathalie Pello Leprince Ringuet
Valérie Perrot
Aurélien Descazeaud

232Background: Both PCa and TDS risk increase with age. Patients may therefore suffer from both conditions, and their quality of life (QoL) be reduced. Unexpectedly, multivariate analysis of the EQ...

Keywords:

Prostate cancer
Pathology
Quality of life
Subgroup analysis
Gonadotropin-releasing hormone
Endocrinology
Testosterone
Agonist
Internal medicine
Medicine
Multivariate analysis
testosterone deficiency
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations